A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

The future of work: Lessons from an emerging global market

by Bushra Naaz, Manager, Deloitte Center of Health Solutions

The future of work is gaining momentum in the US and across the globe. I recently attended the Future of Workplace Summit in Mumbai, India’s financial district. I was curious to hear how companies in this dynamic and fast-paced city are approaching the future of work.

The Deloitte Center of Health Solutions recently conducted research on the future of work for the US health care market.

Read more

As interest in oncology grows, real-world data could help biopharma firms improve clinical research, reduce costs

by Brett J. Davis, General Manager & Principal | ConvergeHealth by Deloitte, Deloitte Consulting LLP

Early this year, I attended the annual J.P. Morgan Healthcare conference where investors and biopharmaceutical company executives were excited about the growth of personalized therapies—particularly in oncology. This optimism was somewhat tempered by some of the many challenges in oncology research and development (R&D) and bringing high-cost therapies to market. However, advances in digital health,

Read more

Provider-sponsored health plans can be at the forefront of the changing health care market

by Maulesh Shukla, Assistant Manager, Deloitte Consulting LLP

I have always been fascinated by simple solutions to seemingly complex problems. Few problems are more vexing than the US health care system. One of the solutions offered by several experts and policy makers is unifying care delivery and financing. Isn’t that simple? If not the solution, at least the articulation of the solution is simple.

Read more

Empowered patients, value, and digital are driving us to a new health model

by Brett J. Davis, General Manager & Principal | ConvergeHealth by Deloitte, Deloitte Consulting LLP

Five years ago—recognizing that the shift to value-based, personalized health care would have a profound and transformational impact on the industry—we launched ConvergeHEALTH. Our goal was to team up with leading health care institutions, technology companies, life sciences innovators, and patient advocacy groups to create new platforms and solutions to support this transformation for the benefit of patients.

Read more

Emerging trends in life sciences indicate cautious optimism for M&A in 2019

by Susan Dettmar, principal, US M&A consultative services leader, and Kushan Biswas, Life Sciences M&A senior manager, Deloitte Consulting LLP

Each year during the second week of January, health care executives from around the globe descend on San Francisco to discuss ground-breaking innovations, investment opportunities, and potential disruptive plays across the life sciences sector. During this year’s J.P. Morgan Healthcare Conference, we hosted a number of sessions with clients. A few topics—continued investment in oncology and gene therapies,

Read more

Investments in new IT tools are helping hospitals steer clear of the margin cliff

by Steve Burrill, Vice Chairman, US Health Care Leader, Deloitte LLP

Over just the past few months, I have noticed that hospitals and health systems are making bigger investments in virtual health and relationship tools that connect clinicians to patients, clinicians to other clinicians, and clinicians to virtual information that allows them to improve patient care. As traditional fee-for-service (FFS) gives way to payment models that reward value over volume,

Read more